Benzinga | Apr 13, 2021 08:54AM EDT

Evercore ISI Group Initiates Coverage On Finch Therapeutics Group with Outperform Rating, Announces Price Target of $34

Evercore ISI Group analyst Maneka Mirchandaney initiates coverage on Finch Therapeutics Group (NASDAQ:FNCH) with a Outperform rating and announces Price Target of $34.